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Abstract 
The polymerase chain re;%ction was used to amplify a cdc2 homologous sequence from Purnmecium tetraureliu. The corresponding 
amino acid sequences exhibits about 50% similarity to the cdc2 proteins of other species. The Paramecium cdc2 encoded protein is 11 
amino acids longer than S. pombe ~34’~‘~. There is one amino acid change in the conserved PSTAIRE region. Southern blot analysis 
indicates that Paramecium has multiple cdc2 genes. Northern blotting results shows that Paramecium cdc2 is much more expressed in 
actively dividing cells. It is almost undetectable in starved stationary cells. The mRNA level of cdc2 gene does not change during the 
vegetative cell cycle. 
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1. Introduction 
The cyclin-dependent kinases (CDKs) are the major 
regulatory proteins of thle eukaryotic cell division cycle. 
The pathway leading to the full activation of these kinases 
is quite complex. Each n’eeds to bind to a member of the 
cyclin family in order to become fully active as a kinase. 
Both the association between each cyclin and CDK pair, 
and the activity of the resulting cyclin-CDK complex are 
closely regulated by phosphorylation of the CDK subunit. 
Once activated, different cyclin-CDK complexes are re- 
sponsible for phosphorylating different substrates that are 
required for cell cycle transitions such as the initiation of 
DNA synthesis (IDS) and entry into mitosis (for review 
see Ref. [l]). The best understood CDK is c&z2 kinase 
(also called CDKI). This kinase has been identified from 
algae, fungi, plants, and animals. In yeast, it is required for 
both Gl/S and G2/M transitions. In higher eukaryotes, 
cdc2 is mainly needed for entry into mitosis. A constant 
pool of cdc2 protein is present throughout the cell cycle in 
both yeast and animal cells, but monomeric cdc2 is un- 
phosphorylated and has no histone Hl kinase (HlK) activ- 
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ity. Binding to cyclin induces phosphorylation at three 
sites: Thr-14, Tyr-1.5, and Thr-167 (Thr-161 in human). 
Thr-161/167 phosphorylation is required for catalytic ac- 
tivity and is carried out by CAK (~40~~~~1, a cdc2-activat- 
ing kinase, itself a member of the cdc2-related kinase 
family [2-41. Thr-14 and Tyr-15 phosphorylations are 
inhibitory. Dephosphorylation of Tyr-15 in fission yeast, 
and of both Tyr-15 and Thr-14 in vertebrates, is required 
for activation of p34cdc2 [5,6]. The protein kinases Wee1 
and Mikl are responsible for phosphorylation of Tyr-15 of 
cdc2 [7,8]. The final step of activation of cdc2 cyclin 
complex is the removal of inhibitory phosphate from Tyr-15 
(and also Thr-14 in vertebrates) by the protein phosphatase 
cdc25 [9]. 
Paramecium cell cycle control is unique when com- 
pared to that of other groups of eukaryotes (for review see 
Ref. [lo]). Two functionally distinctive nuclei in the same 
cytoplasm enter IDS and nuclear division at different times 
111,121. The two critical control points in other eukaryotes, 
IDS and commitment to division, are controlled from a 
single point in the Paramecium cell cycle [lo]. Immuno- 
blotting with an polyclonal antibody rised against a per- 
fectly conserved PSTAIRE region of cdc2 gene family 
showed that there are two closely migrating polypeptides 
of about 34 kDa in Paramecium [13]. The less abundant 
one binds to p13”“” which exhibits a high affinity for 
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cdc2 kinase in all other eukaryotes and cdk2 kinase in 
mammals, while the predominant one does not. The in 
vitro histone Hl kinase (HlK) activity specific to the 
faster migrating polypeptide is associated with the commit- 
ment to division, suggesting that Paramecium cdc2-like 
proteins might function as cell cycle regulators similar to 
cdc2 kinases in other organisms. Here we describe the 
isolation and sequencing of a cdc2-like gene from 
Paramecium tetraurelia, its expression in starved and ex- 
ponentially growing cells, and the pattern of Paramecium 
cdc2 mRNA abundance throughout the cell cycle. 
2. Materials and methods 
2.1. Cell culture and synchronization 
The wild type stock 51-S of Paramecium tetraurelia 
was grown at 27°C in phosphate-buffered Cerophyl medium 
supplemented with 5 pug/ml stigmasterol [14], and inocu- 
lated one day before use with Klebsiella pneumoniae. 
Synchronized cells were prepared by centrifugal elutriation 
as described [13]. 
2.2. DNA and RNA isolation 
Genomic DNA and total RNA were isolated from both 
exponentially growing and starved cells as described [15]. 
Total RNA from synchronized cells was isolated by the 
procedure of Xie and Rothblum [16]. 
2.3. PCR amplification 
The degenerate oligonucleotide primers for PCR 
amplification of a Paramecium cdc2 gene segment were 
designed from the following conserved amino acid se- 
quences of cdc2 kinase: VAMKKIR (forward primer, 
5’-GTIGCIATGAAA/GAAA/GATIAG-3’), WYRAPE 
(reverse primer, 5’-ACT/CTCIGGIGCT/ CCTA/ 
GTACCA3’1, and GCIFAEM (reverse primer, 5’-CATT/ 
CTCIGCA/GAAIATA/GCAICC-J, Fig. 3). The forward 
primer incorporated an XbaI site and the reverse primers a 
XhoI site for cloning of the PCR products. Total genomic 
DNA was used as template. The reaction contained 2 pg 
of genomic DNA, 100 pmol of each primers, 200 PM of 
each dATP, dCTP, dGTP, dT”TP, 2.5 U of Z’aq polymerase 
(BRL), 50 mM Tris-HCl (pH 8.01, 2.0 mM MgCl,, 0.05% 
Tween 20, 0.05% NP-40, in a final volume of 100 ~1. 
Amplification products of the predicted length were iso- 
lated by gel electrophoresis, purified with SephaglasTM 
BandPrep Kit (Pharmacia), digested with XbaI and 
XhoI, and subcloned into the plasmid pBluescript II 
SK + / -(Stratagene) digested with the same two en- 
zymes. 
2.4. Isolation and sequencing of genomic and cDNA cdc2 
gene 
The approach of rapid amplification of genomic ends 
(RAGE) developed by Mizobuchi and Frohman [17] was 
used to isolate 5’-end region. Briefly, genomic DNA was 
digested with Hind111 and ligated into Hind111 digested 
plasmid DNA. The ligates were used as templates for PCR 
using one primer (5’-AAGTTGGGTAACGCCAG-3’) from 
plasmid sequence, and another antisense primer (5’- 
ATGACATGCTTAGATTCCTCT-3’, Fig. 1) from the 
Paramecium cdc2 fragment obtained by PCR with degen- 
erate primers. This PCR product was used as templates for 
a second PCR using two internal primers, one from the 
plasmid (5’-CCAGTCACGACGTTGTA-3’) and another 
from the Paramecium cdc2 PCR fragment (5’-GCCTT- 
TCTCTPTGGGGAATTG-J, Fig. 1). The second PCR 
product was isolated and subcloned into plasmid as de- 
scribed above. 
The 3’-end was isolated by rapid amplification of cDNA 
ends (RACE) [18]. Single stranded cDNA was made from 
total RNA by an oligo-dT,, primer. The PCR reaction was 
carried out using cDNA as templates, primed by oligo-dT 
and another specific oligonucleotide (5’- 
GAGATCTCTCTGCTTAAAGAG-3’ ) from the Parame- 
cium cdc2 fragment (Fig. 1). 
The whole cDNA and genomic DNA sequences were 
isolated by PCR using a forward primer (5’-CTCCAG’IT- 
TATTAGATTTCATAATATT-3’) from 5’-END, and a re- 
verse primer (5’-GAAAGGTTTTATGAAATTTGA- 
TATATA3’) from 3’-end. All DNA sequencing was per- 
formed by the dideoxy chain-termination method using 
double-stranded plasmid templates. A T7 sequencing kit 
(Pharmacia) was used for all sequence determinations by 
following its included protocols. 
2.5. Southern and Northern blot analysis 
For Southern blotting, 20 pg of genomic DNA were 
digested with seven restriction enzymes, separated by 0.8% 
agarose gel and transferred to Hybond-N+ membrane 
(Amersham) using downward technique in 0.4 M NaOH as 
described [19]. The probe was prepared by PCR in the 
presence of digoxigenin-11-dUTP (DIG-ll-dUTP, 
Boehringer-Mannheim), using the following two primers: 
5’-CTCCAGT’ITATTAGATTTCATAATATT-3’ (5’-end 
primer) and 5’-ATGACATGCTTAGATTCCTCT-3’ (3’- 
end primer). The hybridization and detection were per- 
formed as described by Engler-Blum et al. [20] using a 
DIG Luminescent Detection Kit from Boehringer-Man- 
nheim. 
For Northern blots, 20 pg total RNA were separated on 
a 1.2% agarose/formaldehyde gel as described [15], ex- 
cept that 0.22 M formaldehyde was used for both gel and 
electrophoresis running buffer. RNA was blotted to Hy- 
bond-N+ by downward alkaline capillary transfer [21], 
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except for that two buffer containers were used for the 
transfer setup instead of one. The membrane was probed as 
described for Southern blotting. 
3. Results 
3.1. Isolation of a cdc2-homologous sequence from 
Paramecium by PCR 
was amplified by a pair of primers from AMKIUR and 
WYRAPE regions. The PCR reaction with primers from 
AMKKIR and GCIFAEM regions yielded a 510 bp prod- 
uct. Sequencing analysis showed that these two fragments 
were identical in the overlapping region and exhibited a 
high similarity to the cdc2 proteins of other species and 
included the PSTAIRE motif characteristic of the cdc2 
gene family (Fig. 3). 
The remarkable conservation of the ~34’~‘~ kinase 
between highly diverse species allowed us to use PCR to 
isolate homologous sequences from Paramecium. Degen- 
erate primers to AMKKIR, WYRAPE, and GCIFAME 
3.2. Isolation and characterization of cDNA and genomic 
cdc2 
Specific primers were designed from the above PCR 
fragment for isolation of 3’- and 5’-ends by RACE and 
regions were used for PCR (Fig. 3). A 450 bp fragment RAGE as described in Materials and methods. Then two 
TATGGGTGGTTTGTTTGATTTGAT TGiUAATGGAAAAATAAAAATCGTATATTAATATTTATTTAATATT 
ATGAAATCTAATAAACTGGAGAAATACGAGAG~G~GGAG~GCTCGGGG~GGTACTTACGG~TTGTG 
MKSNKLEKYEKKEKLGEGTYGIV 
TATAAGGCATTGGGTATGCATCCTATTATTATTTGCTATTTAGACCGT~CACTAATGAGTATGTGGCG 
Y K A L AA AAD R N T N E Y V A 
ATTAAAP~TCAGACTTGAGTCAGAAGAGGAGG~GGCATTCCTAGTACTGCCATCAGAGAG_AT~~_~TCTT 
IKKIRLESEEEGI PSTAIREISL 
C_TC~~_SGTTGAATCATCCAAACATTGTGAAGTAATACTCGTTCTATCTAGAGATTAATGGAGGTTGTG 
LKELNH P N I V KAA AA L M E V V 
CATTCAAATAAGAAACTTGTACTGGTCTTTGAGTATTTTG~TGGATCTT~G~TTCCTTGCCC~ 346 
HSNKKLVLVFEYFEMDLKKFLAF 98 
TTCCCCAAAGAGAAAGGCATGGAACCCGTGATTGTGAAGAGTTTCCTCTATTAACTCCTAAGAGGAATC 
FPKEKGMEPVIVKSFLYQ*LLRGI 
415 
121 
TAAGCATGTCATTAATA TATTACACCGTGATCTCAAACCTCAAAATCTTTTGGGCTCCAAAGAC 
Q*A C H Q*Q*K I L H R D L K P Q N L L G S K D 
404 
144 
GGAATCCTCAAACTTGCTGATTTTGGACTTGCCAGAGCTAGTGGAATCCCTGTTAAAAGTTTCACTCAT 553 
GILKLADFGLARASGIPVKSFTH 167 
GAAGTTGTCACACTGTGGTACAGACCACCAGATGTCCTGTTGGGCTCTAAAAACTACAACACCTCAATA 622 
EVVTLWYRPPDVLLGSKNYNTSI 190 
GATATCTGGAGTGTGGGCTGCATCTTTGGCGAAATGTCAAATCTTAAACCTCTTTTTGCTGGAAGCAAT 691 
DIWSVGCIFGEMS.NLKPLFAGSN 213 
GAAACTGATCAATTGAATTCAGAGTCTTGGGAATG 
ETDQLKKI FRVLGTPSPIEYPKL 
AATGATCTTCCAAGCTGGAAACCTGACTTTGAACAATACCAACC~CCTGAC~TCTAGCTAAGTTTTGT 
NDLPSWKPENFEQYQPDNLAKFC 
760 
236 
829 
259 
CCAAGACTTGATCCAGATGGCTTAGACTTATTGGTCAAAATGCTTAACCAGATTAAAGAATT 898 
PRLDPDGLDLLVKMLKINPDQ+RI 282 
ACAGCCAAAGCTGCATGTGAATCCCTTCTTCAAAGAATCAGAATAAGTTAAGAAATTATATGTC 967 
TAKAACEHPFFKELPEQ+VKKLYV 305 
-66 
69 
23 
138 
36 
207 
59 
277 
75 
AACGTCAAGTGAGAATTCATAGATCAAATATATATATATATC~TTTCAT~CCTTTCA-17 1027 
N V K * 308 
Fig. 1. Nucleotide and deduced amino acid sequences of Paramecium tetraurelia. * indicates the stop codon TGA. Q * is glutamine encoded by TAA. 
The regions upon which the primers were designed for RAGE are underlined and that for RACE is double underlined. Two short introns are present in the 
sequence. Pairs of GT/AG specific to eukaryotic introns are indicated by filled triangles. The first stop codon before the start codon is indicated by bold 
italic. 
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Fig. 2. PCR amplification from the two intron regions. Lanes 1 and 2 
correspond to the PCR products obtained with the first set of primers 
(primer 1: 5’-ATGAAATCTAATAACTGG-3’ and primer 2: 
S’TCTGATGGCAGTACTAGG-3’) surrounding intron 1; lanes 5 and 6 
to those obtained with the second set of primers (primer 3: 5’- 
GAGATCTCTCTTCTCAAAG-3’ and primer 4: S-ATAGAG- 
GAAACTCTTCAC-3’) surrounding the second intron; lanes 3 and 4 to 
those obtained with set of primers 1 and 4 surrounding both introns. 
Lanes 1, 3 and 5 are the amplification from genomic DNA, lanes 2, 4 and 
6 from cDNA after reverse transcription from total RNA. The size 
markers (lane M, kilobases, BRL) are indicated on the left of the figure. 
primers from both ends of the gene were made for PCR to 
isolate the full sequence from both genomic and cDNA. 
The nucleotide sequence and its translation are shown in 
Fig. 1. Comparison between cDNA and genomic DNA 
sequences shows that Paramecium cdc2 contains two 
short intervening sequences, one is 30 nucleotides and 
another only 22 nucleotides. Both introns contain consen- 
sus splicing sites GT/AG, neither contains any in-phase 
stop codons. This is the second case of introns described in 
protein encoding genes in Paramecium. Two 27 bp introns 
are present in Paramecium tubulin gene [22]. The 22 bp 
intron is the shortest intron reported to date [23]. The 
second intron is located at the same place as the second 
intron of four in S. pombe cdc2 1241. PCR amplification 
using primers encompassing these two intron sequences 
from mRNA-derived cDNA and genomic DNA confirmed 
that these two short sequences are absent from Parame- 
cium mRNA (Fig. 2). 
A comparison of the derived amino acid sequence with 
those of the cdc2 proteins from other eukaryotes is shown 
in Fig. 3. It has 308 amino acids compared to 288-298 
amino acids from other organisms. The Paramecium pro- 
tein has additional amino acids at both of its N- and 
C-terminal regions relative to cdc2 of S. pombe [24]. At 
the amino acid level, the Paramecium gene is only 41% 
similar to T. vaginalis [25], 46% to E. histolytica [26], 
60% to P. falciparum [27], 56% to cdc28 of S. cerevisiae 
[28], 53% to S. pombe cdc2 [24], 59% to that of 2. mays 
[29], 55% to cdc2 of D. discoideum [30], and 54.5% to 
that of human [31]. There is absolute conservation of the 
ATP-binding site motif (amino acids 16-21, GEGTYG, 
Fig. 3) where two important regulatory phosphorylation 
sites, threonine and tyrosine, are located. Another regula- 
tory threonine residue (Thr-161/167, Thr-166 in Parame- 
cium, Fig. 3) is also conserved. The major differences 
between Paramecium cdc2 sequences and other cdc2 se- 
quences are: one amino acid change (V to I) within the 
p34”d’2 hallmark ‘PSTAIRE’ sequence motif; only two 
tryptophan residues out of four found to be conserved in 
all other cdc2 proteins; two substitutions in the conserved 
WYRAPE region (Fig. 3). 
Southern blotting analysis showed at least 2 hybridiza- 
tion bands when digested with 7 different restriction en- 
zymes (Fig. 4). There was always one stronger band in 
each digestion (Fig. 4). If longer exposure is used, 3-5 
bands can be seen from each digestion (data not shown). 
We suggest that there are at least two members of the cdc2 
gene family in Paramecium. Sequence analysis of several 
RACE-PCR product clones showed that there were two 
classes of closely related, but different cDNA clones. The 
second sequence was truncated at the 5’-end by 165 bp as 
compared to the full sequence of the first gene (unpub- 
lished data). This further substantiates that Paramecium 
has more than one cdc2 related sequences. 
3.3. Paramecium cdc2 transcripts are abundant in actively 
dividing cells 
In S. pombe, the level of cdc2 transcript does not 
change during a shift between cell proliferation and sta- 
tionary phase or during the mitotic cell cycle [32], but 
cdc2 mRNA decreases in non-dividing cells of adult plant 
tissues [29]. Transcription of human cdc2 gene is cell 
cycle-regulated and restricted to proliferating cells [33]. It 
was of interest to determine whether the cdc2 transcript 
was present at levels that reflect the replicative acvtivity of 
Paramecium cell. Total RNA was isolated from exponen- 
tially growing cells and from cells starved for 7 days. 
More than 90% of starved cells were in autogamy. North- 
em blots analysis showed that a single mRNA of approx. 
1.3 kb was present in Paramecium cells (Fig. 5). Unlike 
its homologue in S. pombe, the Paramecium cdc2 mRNA 
was most abundant in actively dividing cells. The expres- 
Fig. 3. Comparison of amino acid sequences of cdc2 proteins from Paramecium tetraurelia (Pt), Trichomonas vaginalis (TV), Entamoeba histolytica (Eh), 
Plasmodium falciparum (Pf), Dictyostelium discoideum (Dd), Saccharomyces cerevisiae (SC), Schizosaccharomyces pombe, Zea mays (Zm) and human 
(Hs). Dashes indicate identity with Paramecium sequence, and dots indicate positions of spacers required to maximally align sequences. The highly 
conserved domains upon which the degenerate primers were based are underlined. The PSTAIRE region is double underlined. Four conserved tryptophan 
residues are indicated by asterisks. Arrows indicate conserved catalytic acidic residues [35]. Filled triangles indicate the residues involved in interaction 
with other cell cycle components [40]. 
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. . . . D-SA-H-D~--------S-~R-.. .THIP-DQP-VL-LV-MDL--D--- 
-...... ~~----QQ-~-~~~-~_~_-W-...TVC-R--_L-~~KQL~~~~~~ 
. . . . . -~~~~~--~---~~~~____~~~~Q~-YG-TF-L-_---~~~~~~~~~~ 
IE-DGG_SR_*_~_--_---__K____.. .KEKA-GRM--L-J----..DD-V- 
-S..GE-AN-KRL--V------ ~~~~---~~~~Q~Q~~--~--~~~---~~-~- 
-E.... *~N-*-V--~-_----V----_~* RHKLSGRI--M------D-S--V- 
-E.... ..Q_--v--I------V-----_... ~~~~-~~-~----~-Q~~~~~- 
-E...... ~_~-~--~___---~___~~~~~~~~-~Q~-_~__~~~~~~-~~~~ 
A 
PK..EKGMEPVIVKSFLYQLLRGIQACHQQKILHRDLKPQNLLGSKDGI.LKLA 
R . . . . ..-N-DLLR-YAF---C-TYYL-RIG-V---I--E-I-IDRN-L.---G 
s-.... .IPINETR-IV--I-Q-LAF--YHQ-----M----I-IN-N-T.I--G 
E . . . . ~_~_~_~~-_-_~___~__~Y-KDRRV---____________~~~~-~~-_~_ 
-A.... .LC-QLI--Y ~~~-~~~~~~~~~~~~~~_____-_-IDRQ-A.---- 
~-~~~Q~~~~~---~-~~~~~~~~Y-_SHR~~----_~~~~~~~~~~~~~~~~~~~~~~~ 
SETGATSLD-RL-QK-T---VN-VNF--SRR-I----------ID-E-N.---- 
-E... FAKN-TLI--Y---I-8-VAY--SHRV-----------IDRRTNA---- 
~~~~~Q~-~~~~~~~~~~~~~Q~~~~~~SRRV--_~~~~~~~~~~~~~~~~~~~~~~ 
+ 
DFGLARASGIPVKSFTHEVVTLW*YRPPDVLLGSKNYNTSIDI~SVGCIFGEMSN 
---T-AYCFH-IPYDIE-IK-P--LA-EI-INAPAHG-E-----I--VIA--AR 
E -----LTT-NDRKY-S--------A-EI---ATQ-GGA-----D~----LI- 
_______ ____~~~~~~~~~~~~~~~---~---~-~-~----------~--~- F 
-------VS---RVy---I ~~~~~-A~~~~~_~-S~SVPV-~----------L- 
~~~~~~~~~~~~~~~~~~~~~~~~~-E----G-Q-S-~~Q~~~~~~~--~----~--~- 
------SF-V-LRNY--- ~~~~~~~~~~~~~~~~~~~-~~---------~--~~ 
_______ ~~~~~~-----------~~~~---~~Q-S-PV-V----_--~--~- F 
~~-~~~~F-_-IRVY~~~~~~~~~~A~~-----AR-S-PV~~~~I-T--A-~T 
+ AAA + + 
LKPLFAGSNETDQLKKIFRVLGTPSPIE:PKLNDLPSWKPENFE~YQPDN~KF 
-.N--M-DSQV---I--TE---I--EED--DFYKYKINNMPCMKKEK--.FNS- 
KEE--K-RCKI--- F---SQ----TEDIWNGVTK--FYLSTFPKWKAK-..LHY 
GT--- P-VS-A---MR--- I----NSKNW-NVTE--KYD-NFTVYEPLP.WES- 
ti----S-DC-I--IFR--------DDSIW-GVTK--EYVSTFPNWPGQP.YN-I 
R--I-S-DS-I--IF--------- NEAIW-DIVY--DF--SFPQWRRK-.-SQV 
RS--- P-DS-I-EIF---Q-----NEEVW-GVTL-QDY-STFPRWKRM-.-H-V 
Q ~~~~~~~~-~-~-~~~~~~~~-_ NEQSW-GVSC--DF-TAFPRWQAQ-.--TV 
K----H-DS-I--- FR---A----NNEVW-EVES-QDY-NTFPKWKPGS.--SH 
A A A A 
CPRLDPDGLDLLIKMLKINPDQRITAKAACEHPFFKELPEQVKKLYVNVK 
F-GV--ELV--IS---QM--EH--N-QS-LN--Y--DVN-NL-HTCME 
IFHT-ERAV--- Q--FIYT-EK--S-AD-LK----DP-NKPNN 
LKG-~~S-I~--L----LD-N~--~~~Q~L~~AY~~~NN 
F--CE-LA--- IA---QYE-SK--S--E-LL--Y-GD-DTSFF 
V-S---R----ID-L-AYD-IN--S-RR-AI--Y-Q-S 
V-NGEE-AIE-ISA--VYD-AH--S--R-LQQNYLRDFH 
~-~~~~~-~~~~~~-~~~~-sK----RQ-L~---D_E~Q 
VKN--EN-----S-e- IYD-AK--SG-M-LN--Y-ND-DN-I--M 
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Fig. 4. Southern blot analysis. 20 pg of paramecium genomic DNA was 
digested with BamHI (lane l), EcoRI (lane 21, Hind111 (lane 3), TaqI 
(lane 4), XbaI (lane 5), XhoI (lane 6), PstI (lane 7), and probed as 
described in Materials and methods. The molecular sizes (kilobases, 
BRL) are indicated on the right (lane M). 
sion in starved cells was almost undectable compared to 
that of actively dividing cells (Fig. 5, lane 13). However, a 
weak 1.3 kb band was visible in starved cells after a longer 
exposure (data not shown). 
To determine the relative expression of cdc2 transcripts 
during the cell cycle, Gl cells were enriched by centrifugal 
elutriation, harvested at 1 h intervals. The total RNA was 
Fig. 5. Expression of Paramecium cdc2 gene during the cell cycle by 
Northern blot analysis. The same amount of total RNA (20 pg) was 
loaded on each lane and probed as described under Materials and 
methods. Synchronized samples were collected at 1 h intervals from O-11 
h after elutriation (lanes 1-12). Lane 13, starved cells, lane 14, non-syn- 
chronized cells, lame M, RNA molecular size standard (BRL). 
isolated for Northern blotting (Fig. 5, lanes 1-12). Cell 
synchrony was monitored by both hand selection and cell 
density [13]. More than 90% of synchronized cells were 
divided between 7.5 and 9 h (data not shown). As shown 
in Fig. 5, the amount of Paramecium cdc2 transcripts 
remained relatively constant throughout the cell cycle, 
indicating that in Paramecium the cdc2 kinase is not 
regulated at transcriptional level during the cell cycle. 
4. Discussion 
With a combination of different PCR approaches, we 
isolated a full Paramecium cdc2 sequence, corresponding 
to a 308 amino acid polypeptide. In the previous report, we 
showed that there are two polypeptides in Paramecium 
recognized by anti-PSTAIRE antibody [13]. The major one 
migrates slower than S. pombe p34 and the minor one 
migrates at the same rate. A polyclonal antibody rised 
against our isolated sequence recognized the major, slower 
migrating polypeptide cross-reacting with anti-PSTAIR an- 
tibodies (data not shown). This slow-migrating peptide 
does not show appreciable p13 binding, unlike the more 
rapidly migrating form [13]. Other cdc2-like proteins with 
weak or negligible p13 binding have been identified, e.g., 
human cdk3 [34]. However, the Paramecium sequence 
shows no higher identity to cdk3 than cdc2. 
The structural homology of Paramecium cdc2 to cdc2 
kinases from other organisms is obvious. Among the five 
acidic amino acids that are conserved in protein kinases 
and required for S. pombe cdc2 function [35], four of them 
are conserved in Paramecium, and the glutamic acid in 
domain VIII [36] is substituted by aspartic acid (Fig 3). 
This aspartic acid is also present in Plasmodium [27]. The 
major regulatory phosphorylation sites (Thr-14, Tyr-15, 
and Thr-161/167) are conserved also. Another phospho- 
serine reported in vertebrates is replaced by a threonine. 
However, this threonine residue is conserved between 
Plasmodium, plant and Paramecium [27,29,37]. All these 
suggest that the isolated gene may have the same function 
and may be regulated in a similar way as S. pombe cdc2 
kinase. However, p13’“” binding sites are not conserved 
between Paramecium cdc2, S. pombe cdc2 and human 
cdc2 [38,39]. This further supports our assignment of 
cdc2Pt to the slower migrating peptide recognized by 
anti-PSTAIRE. Nine residues thought to be involved in 
cdc2-specific interactions with other cell cycle control 
elements are conserved in all known functional ~34’~” 
homologues but absent at the equivalent positions from all 
other known protein kinases [36,40]. Surprisingly, only 
two are present in Paramecium sequence (Fig. 3). This 
supports our previous observation that Paramecium cdc2- 
like kinases do not need to form complexes with other cell 
cycle components to become active histone Hl kinase [13]. 
However, all of the known cyclin-binding sites in S. 
pombe ~34’~‘~ and human cdc2 are conserved in Parame- 
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cium cdc2 [39,41]. A key functional and perfect con- 
serverved 16 amino acids in higher eukaryoes (PSTAIRE 
region) [42], EGIPSTAIREISLLKE, is not very conserved 
in lower eukaryotes (Fig. 3). In Paramecium there is one 
amino acid change, two changes in Dictyostelium [30], 
four changes in PZasmod,ium [27]. The PSTAIRE region is 
not conserved in Trichomonas or Entamoeba [25,26]. The 
Paramecium cdc2 sequence should help further define 
conserved, functionally important regions of cdc2. 
In yeast and Dictyostelium, cdc2 mRNA levels do not 
decrease as cells enter stationary phase from exponential 
growth [30,32]. However., in multicellular organisms, cdc2 
gene expression is very low in differentiated tissues or 
serum-starved culture cells [29,33]. In addition, human 
cdc2 is regulated at the transcriptional level [33]. Parame- 
cium cdc2 transcription is almost undetectable at stationary 
phase, but occurs at much higher levels and does not 
change appreciably during the cell cycle, suggesting that 
the Paramecium cdc2 expression pattern reflects a state 
comparable to that of differentiated metazoan cells. 
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